In conclusion, CT perfusion parameters and serum VEGF and BFGF levels in patients with primary liver cancer are abnormally expressed, and there is a strong correlation between the two, which might benefit clinical diagnosis and treatment. The gene discussed is FGF2; the disease is liver cancer.